Establishment of induced pluripotent stem cell line (ZZUi009-A) from an Alzheimer's disease patient carrying a PSEN1 gene mutation

Establishment of induced pluripotent stem cell line (ZZUi009-A) from an Alzheimer's disease patient carrying a PSEN1 gene mutation

Skin fibroblasts were obtained from a 42-year-old Alzheimer's disease (AD) patient carrying mutations in the PSEN1 gene. An iPSC line was successfully established using the Sendai-virus (SeV) delivery system. The patient-specific iPSCs were free of genomically integrated reprogramming genes, ha...

Full description

Bibliographic Details
Main Authors:	Yanlin Wang, Na Jing, Linlin Su, Changhe Shi, Pei Zhang, Zhilei Wang, Huifang Sun, Jing Yang, Yutao Liu, Xuejun Wen, Jin Zhang, Shoutao Zhang, Yuming Xu
Format:	Article
Language:	English
Published:	Elsevier 2018-03-01
Series:	Stem Cell Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1873506117302647

Similar Items

Establishment of induced pluripotent stem cell line (ZZUi010-A) from an Alzheimer's disease patient carrying an APP gene mutation
by: Zhilei Wang, et al.
Published: (2017-12-01)

Generation of induced pluripotent stem cell line (ZZUi011-A) from urine sample of a normal human
by: Huifang Sun, et al.
Published: (2018-05-01)

Generation of induced pluripotent stem cell line(ZZUi006-A)from a patient with myotonic dystrophy type 1
by: Yanlin Wang, et al.
Published: (2018-10-01)

Generation of induced pluripotent stem cell line (ZZUi004-A) from urine sample of a patient with spinocerebellar ataxia type 3
by: Yanlin Wang, et al.
Published: (2018-04-01)

Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson’s disease
by: Yanlin Wang, et al.
Published: (2018-10-01)

Generation of induced pluripotent stem cell line (ZZUi0013-A) from a 65-year-old patient with a novel MEOX2 gene mutation in Alzheimer's disease
by: Yanlin Wang, et al.
Published: (2019-01-01)

Generation of induced pluripotent stem cell line (ZZUi0016-A) from dermal fibroblasts of a normal human
by: Yuan Gao, et al.
Published: (2020-03-01)

Generation of induced pluripotent stem cell line (ZZUi0024-A) from a 51-year-old patient with APP gene mutation in Alzheimer’ s disease
by: Zhuoya Wang, et al.
Published: (2021-05-01)

Generation of induced pluripotent stem cell line (ZZUi0014-A) from a patient with spinocerebellar ataxia type 3
by: Yanlin Wang, et al.
Published: (2019-12-01)

Generation of induced pluripotent stem cell line (ZZUi019-A) derived from skin fibroblasts from a healthy volunteer
by: Yanlin Wang, et al.
Published: (2021-05-01)

Construction of induced pluripotent stem cell line (ZZUi0017-A) from the fibroblast cells of a female patient with CACNA1A mutation by unintegrated reprogramming approach
by: Jing Yang, et al.
Published: (2020-10-01)

Generation of induced pluripotent stem cell line (ZZUi0026-A) from a patient with spinocerebellar ataxia type 3
by: Jing Fang, et al.
Published: (2021-05-01)

Generation of induced pluripotent stem cell line (ZZUi028-A) from a 52-year-old Chinese Han healthy female individual
by: Yanlin Wang, et al.
Published: (2021-05-01)

Generation of induced pluripotent stem cell line (ZZUi027-A) derived from skin fibroblasts from a Parkinson’s disease patient with RAB39B gene mutation
by: Huifang Sun, et al.
Published: (2021-08-01)

Generation of induced pluripotent stem cell line (ZZUi0018-A ) from a patient with spinocerebellar ataxia type 6
by: Ting Yang, et al.
Published: (2020-04-01)

Generation of induced pluripotent stem cell line (ZZUi005-A) from a 21-year-old patient with a novel RAB39B gene mutation in X-linked juvenile parkinsonism
by: Yanlin Wang, et al.
Published: (2017-12-01)

Generation of induced pluripotent stem cell line (ZZUi0012-A) from a patient with Fahr's disease caused by a novel mutation in SLC20A2 gene
by: Qinxian Zhang, et al.
Published: (2019-03-01)

Generation of induced pluripotent stem cell line (ZZUi030-A) from a patient with spastic paraplegia type 7
by: Qi Zhang, et al.
Published: (2021-10-01)

Generation of an induced pluripotent stem cell line (ZZUi022-A) from a paroxysmal kinesigenic dyskinesia individual carrying the PRRT2 gene mutation
by: Liyuan Fan, et al.
Published: (2021-03-01)

Generation of induced pluripotent stem cell line (ZZUi0021-A) from a patient with spinocerebellar ataxia type 19
by: Fen Liu, et al.
Published: (2021-05-01)

Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1
by: Tong Li, et al.
Published: (2016-03-01)

APP, PSEN1, and PSEN2 Variants in Alzheimer’s Disease: Systematic Re-evaluation According to ACMG Guidelines
by: Xuewen Xiao, et al.
Published: (2021-06-01)

Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a M146I mutation in PSEN1
by: Tong Li, et al.
Published: (2016-03-01)

Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 gene
by: L. Auboyer, et al.
Published: (2019-01-01)

Establishment of PSEN1 mutant induced pluripotent stem cell (iPSC) line from an Alzheimer's disease (AD) female patient
by: Csilla Nemes, et al.
Published: (2016-07-01)

Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families.
by: Carlos Cruchaga, et al.
Published: (2012-01-01)

Correction: Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families
by: Carlos Cruchaga, et al.
Published: (2012-01-01)

<i>APP, PSEN1</i>, and <i>PSEN2</i> Mutations in Asian Patients with Early-Onset Alzheimer Disease
by: Vo Van Giau, et al.
Published: (2019-09-01)

APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
by: Hélène-Marie Lanoiselée, et al.
Published: (2017-03-01)

Generation of an induced pluripotent stem cell line (SDQLCHi009-A) from a patient with 47,XXY and ornithine transcarbamylase deficiency carrying a hemizygote mutation in OTC
by: Xiaomeng Yang, et al.
Published: (2020-03-01)

Establishment of an induced pluripotent stem cell line ZZUi003-A from a 65-year-old male with sporadic Parkinson's disease
by: Xiangyu Zheng, et al.
Published: (2017-08-01)

Generation of a human induced pluripotent stem cell line from a familial Alzheimer's disease PSEN1 T119I patient
by: Luciana Isaja, et al.
Published: (2021-05-01)

Generation and characterization of human induced pluripotent stem cell lines from a familial Alzheimer's disease PSEN1 A246E patient and a non-demented family member bearing wild-type PSEN1
by: Sonia Sanz Muñoz, et al.
Published: (2018-08-01)

Generation of an induced pluripotent stem cell line (ZZUi034-A) from a 65 year old Chinese female donor with sendai virus reprogramming protocol
by: Dai, Y., et al.
Published: (2022)

Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2
by: Simon Hsu, et al.
Published: (2020-06-01)

Establishment of TUSMi009-A, an induced pluripotent stem cell (iPSC) line from a 24-year-old Chinese Han patient with gliocytoma
by: Kui Chen, et al.
Published: (2021-10-01)

Generation of a human induced pluripotent stem cell (iPSC) line from skin fibroblasts of a patient carrying an E363Q mutation in PSEN1 gene
by: Chu, S., et al.
Published: (2022)

A Three-Dimensional Alzheimer’s Disease Cell Culture Model Using iPSC-Derived Neurons Carrying A246E Mutation in PSEN1
by: Mercedes A. Hernández-Sapiéns, et al.
Published: (2020-06-01)

PSEN as an Educational Tool in Norway
by: Tormod Schumacher Westvik, MD
Published: (2017-09-01)

Generation of an induced pluripotent stem cell line (ZZUi020-A) from a patient with Parkinson’s disease harboring the intermediate-length GGC repeat expansions in the NOTCH2NLC gene
by: Yu Fan, et al.
Published: (2021-04-01)